194 related articles for article (PubMed ID: 20710013)
41. Semiquantitative detection of JCV-DNA in peripheral blood leukocytes from HIV-1-infected patients with or without progressive multifocal leukoencephalopathy.
Andréoletti L; Lescieux A; Lambert V; Si-Mohamed A; Matta M; Wattré P; Bélec L
J Med Virol; 2002 Jan; 66(1):1-7. PubMed ID: 11748651
[TBL] [Abstract][Full Text] [Related]
42. Brief Report: Role of Thymic Reconstitution in the Outcome of AIDS-Related PML.
Chalkias SG; Gheuens S; Bord E; Batson S; Koralnik IJ
J Acquir Immune Defic Syndr; 2015 Dec; 70(4):357-61. PubMed ID: 26181821
[TBL] [Abstract][Full Text] [Related]
43. Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment.
Ferrante P; Delbue S; Pagani E; Mancuso R; Marzocchetti A; Borghi E; Maserati R; Bestetti A; Cinque P
J Neurovirol; 2003; 9 Suppl 1():42-6. PubMed ID: 12709871
[TBL] [Abstract][Full Text] [Related]
44. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
[TBL] [Abstract][Full Text] [Related]
45. Progressive multifocal leukoencephalopathy: JC virus induced demyelination in the immune compromised host.
Hou J; Major EO
J Neurovirol; 2000 May; 6 Suppl 2():S98-S100. PubMed ID: 10871795
[TBL] [Abstract][Full Text] [Related]
46. Cellular and humoral immune response in progressive multifocal leukoencephalopathy.
Weber F; Goldmann C; Krämer M; Kaup FJ; Pickhardt M; Young P; Petry H; Weber T; Lüke W
Ann Neurol; 2001 May; 49(5):636-42. PubMed ID: 11357954
[TBL] [Abstract][Full Text] [Related]
47. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.
Wijburg MT; Kleerekooper I; Lissenberg-Witte BI; de Vos M; Warnke C; Uitdehaag BMJ; Barkhof F; Killestein J; Wattjes MP
JAMA Neurol; 2018 Jul; 75(7):827-833. PubMed ID: 29532061
[TBL] [Abstract][Full Text] [Related]
48. HIV-associated PML: changing epidemiology and clinical approach.
Simpson DM
Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S24-7. PubMed ID: 22123930
[TBL] [Abstract][Full Text] [Related]
49. Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial?
Du Pasquier RA; Koralnik IJ
J Neurovirol; 2003; 9 Suppl 1():25-31. PubMed ID: 12709868
[TBL] [Abstract][Full Text] [Related]
50. JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy.
Koralnik IJ; Wüthrich C; Dang X; Rottnek M; Gurtman A; Simpson D; Morgello S
Ann Neurol; 2005 Apr; 57(4):576-80. PubMed ID: 15786466
[TBL] [Abstract][Full Text] [Related]
51. Human polyomavirus JC latency and reactivation status in blood of HIV-1-positive immunocompromised patients with and without progressive multifocal leukoencephalopathy.
Andréoletti L; Dubois V; Lescieux A; Dewilde A; Bocket L; Fleury HJ; Wattré P
AIDS; 1999 Aug; 13(12):1469-75. PubMed ID: 10465069
[TBL] [Abstract][Full Text] [Related]
52. Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy.
Dong-Si T; Gheuens S; Gangadharan A; Wenten M; Philip J; McIninch J; Datta S; Richert N; Bozic C; Bloomgren G; Richman S; Weber T; Clifford DB
J Neurovirol; 2015 Dec; 21(6):637-44. PubMed ID: 25771865
[TBL] [Abstract][Full Text] [Related]
53. A review of progressive multifocal leukoencephalopathy in persons with and without AIDS.
Dworkin MS
Curr Clin Top Infect Dis; 2002; 22():181-95. PubMed ID: 12520654
[No Abstract] [Full Text] [Related]
54. Analysis of the transcriptional control region of JC polyomavirus in cerebrospinal fluid from HIV-negative patients with progressive multifocal leucoencephalopathy.
Fedele CG; Polo C; Tenorio A; Niubò J; Ciardi MR; Pérez JL
J Med Virol; 2006 Oct; 78(10):1271-5. PubMed ID: 16927288
[TBL] [Abstract][Full Text] [Related]
55. Clinical Profile and Outcome of Progressive Multifocal Leukoencephalopathy in HIV Infected Indian Patients.
Shah V; Toshniwal H; Shevkani M
J Assoc Physicians India; 2017 Mar; 65(3):40-44. PubMed ID: 28462542
[TBL] [Abstract][Full Text] [Related]
56. Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.
Sainz-de-la-Maza S; Casado JL; Pérez-Elías MJ; Moreno A; Quereda C; Moreno S; Corral I
Eur J Neurol; 2016 May; 23(5):919-25. PubMed ID: 26914970
[TBL] [Abstract][Full Text] [Related]
57. Dual qualitative-quantitative nested PCR for detection of JC virus in cerebrospinal fluid: high potential for evaluation and monitoring of progressive multifocal leukoencephalopathy in AIDS patients receiving highly active antiretroviral therapy.
García de Viedma D; Alonso R; Miralles P; Berenguer J; Rodriguez-Créixems M; Bouza E
J Clin Microbiol; 1999 Mar; 37(3):724-8. PubMed ID: 9986840
[TBL] [Abstract][Full Text] [Related]
58. [Two patients with progressive multifocal leukoencephalopathy with immune response against JC virus showing good long-term outcome by combination therapy of mefloquine, mirtazapine, and risperidone].
Akagawa Y; Ueno A; Ikeda J; Ishii W; Shishido-Hara Y; Sekijima Y
Rinsho Shinkeigaku; 2018 May; 58(5):324-331. PubMed ID: 29710027
[TBL] [Abstract][Full Text] [Related]
59. BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy.
Chen Y; Trofe J; Gordon J; Autissier P; Woodle ES; Koralnik IJ
J Clin Virol; 2008 Jun; 42(2):198-202. PubMed ID: 18295538
[TBL] [Abstract][Full Text] [Related]
60. JC virus-associated central nervous system diseases in HIV-infected patients in Brazil: clinical presentations, associated factors with mortality and outcome.
Piza F; Fink MC; Nogueira GS; Pannuti CS; Oliveira AC; Vidal JE
Braz J Infect Dis; 2012; 16(2):153-6. PubMed ID: 22552457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
